Sarcoma Subcommittee

Purpose

The Sarcoma Subcommittee is a subcommittee of the Developmental Therapeutics Committee and promotes the following primary goals: 1) build a more robust sarcoma program in NRG Oncology’s research portfolio, 2) serve as a resource for NRG Oncology investigators, 3) collaborate closely with the Children’s Oncology Group in the development of protocols for adolescent young adult (AYA) patients and 4) collaborate closely with counterparts in the other NCTN adult groups to promote sarcoma research.

 

Sarcoma Subcommittee Leadership

Chair

Dian Wang, MD, PhD, MD PhD

Vice Chair

William Tseng, MD
Core Committee Members
  • Safia K. Ahmed
  • Anthony J. Apicelli, III
  • Amy Armstrong
  • Parul N. Barry
  • Manpreet (Meena) Bedi, MD, MS
  • Sminu Bose
  • Ludimila Cavalcante
  • Jessica A. Cintolo-Gonzalez
  • Tomás Yokoo Teodoro de Souza
  • Thomas F. DeLaney
  • Edwin Choy
  • Leighton A. Elliott
  • Matthew D. Hall
  • Peter Hendrickson
  • Ying J. Hitchcock
  • Steven B. Holloway
  • Alexandra C. Istl
  • Megan H. Jagosky
  • David G. Kirsch, PhD, FASTRO, FAAAS
  • David Konieczkowski
  • Prashanth Ashok Kumar
  • Katie N. Lee
  • Daniel S. Lefler
  • Atrayee Basu Mallick
  • Arash O. Naghavi
  • Jason D. Nosrati
  • Scott H Okuno
  • Michael S. Rutenberg
  • Naoyuki G. Saito
  • Kilian E. Salerno
  • Tom Scharschmidt
  • James M.G. Tsui
  • Mia C. Weiss
  • Meng Xu Welliver
  • H. Catherine Wilbur
  • Philip Wong
  • Mehran Yusuf

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.